[go: up one dir, main page]

ES8600059A1 - Procedimiento para la preparacion de un plasmido recombinante insertado con el gen del virus de la hepatitis b. - Google Patents

Procedimiento para la preparacion de un plasmido recombinante insertado con el gen del virus de la hepatitis b.

Info

Publication number
ES8600059A1
ES8600059A1 ES83524942A ES524942A ES8600059A1 ES 8600059 A1 ES8600059 A1 ES 8600059A1 ES 83524942 A ES83524942 A ES 83524942A ES 524942 A ES524942 A ES 524942A ES 8600059 A1 ES8600059 A1 ES 8600059A1
Authority
ES
Spain
Prior art keywords
hepatitis
virus
recombinant plasmid
gene
yeast
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES83524942A
Other languages
English (en)
Other versions
ES524942A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Institute of Advanced Industrial Science and Technology AIST
Original Assignee
Agency of Industrial Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency of Industrial Science and Technology filed Critical Agency of Industrial Science and Technology
Publication of ES524942A0 publication Critical patent/ES524942A0/es
Publication of ES8600059A1 publication Critical patent/ES8600059A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE UN PLASMIDO RECOMBINANTE INSERTADO CON EL GEN DEL VIRUS DE LA HEPATITIS B.COMPRENDE: RECOMBINAR UN GEN DE ANTIGENO DE HBS EN UN VECTOR REVERSIBLE EN EL SENTIDO DE LA REGION DE CONTROL DE LA EXPRESION DEL GEN DE FOSFATASA ACIDA REPRIMIBLE PORTADO SOBRE EL VECTOR, CONTENIENDO DICHO VECTOR REVERSIBLE UN GEN DE LEVADURA Y UN GEN DE E. COLI Y LLEVA LA REGION DE CONTROL DE LA EXPRESION DEL GEN DE FOSFATASA ACIDA REPRIMIBLE DE LEVADURA.
ES83524942A 1982-08-16 1983-08-12 Procedimiento para la preparacion de un plasmido recombinante insertado con el gen del virus de la hepatitis b. Expired ES8600059A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57142460A JPS5931799A (ja) 1982-08-16 1982-08-16 Ｂ型肝炎ウイルス遺伝子を組込んだ組換えプラスミド

Publications (2)

Publication Number Publication Date
ES524942A0 ES524942A0 (es) 1985-10-01
ES8600059A1 true ES8600059A1 (es) 1985-10-01

Family

ID=15315829

Family Applications (2)

Application Number Title Priority Date Filing Date
ES83524942A Expired ES8600059A1 (es) 1982-08-16 1983-08-12 Procedimiento para la preparacion de un plasmido recombinante insertado con el gen del virus de la hepatitis b.
ES540895A Expired ES8802162A1 (es) 1982-08-16 1985-03-01 Un procedimiento para la preparacion de una levadura trans- formada con un plasmido recombinante insertado con el gen del virus de la hepatitis b.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES540895A Expired ES8802162A1 (es) 1982-08-16 1985-03-01 Un procedimiento para la preparacion de una levadura trans- formada con un plasmido recombinante insertado con el gen del virus de la hepatitis b.

Country Status (8)

Country Link
US (1) US4778761A (es)
JP (1) JPS5931799A (es)
KR (1) KR890000096B1 (es)
CA (1) CA1270217A (es)
DK (1) DK169953B1 (es)
ES (2) ES8600059A1 (es)
IL (1) IL69423A0 (es)
SU (1) SU1387878A3 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2125047B (en) * 1982-08-09 1986-02-19 Ciba Geigy Ag Yeast hybrid vectors and their use for the production of polypeptides
JPS5936699A (ja) * 1982-08-20 1984-02-28 Chemo Sero Therapeut Res Inst シヤトルベクタ−
JPS5974985A (ja) * 1982-10-19 1984-04-27 Takeda Chem Ind Ltd 新規ｄｎａ
JPS61139391A (ja) * 1984-12-11 1986-06-26 Chemo Sero Therapeut Res Inst 単純ヘルペスウィルス遺伝子を組込んだ組換えプラスミドおよび形質転換酵母
US4816564A (en) * 1986-01-31 1989-03-28 Merck & Co., Inc. Method for producing hepatitis B virus proteins in yeast
US5190877A (en) * 1987-09-03 1993-03-02 Gist-Brocades N.V. Saccharomyces strains for maltose fermentation
US4883865A (en) * 1987-09-30 1989-11-28 Merck & Co. Inc. Recovery of pres2+s antigen
AP129A (en) * 1988-06-03 1991-04-17 Smithkline Biologicals S A Expression of retrovirus gag protein eukaryotic cells
US6319501B1 (en) * 1990-07-19 2001-11-20 Health Research, Inc. Method of immunizing against hepatitis B virus
LT3988B (en) 1992-02-17 1996-06-25 Fermentas Biotech Inst Recombinant plasmides pfs19, pfps2-48 and pjlfds1 codingsynthesis of human hepatite b of surfice virus antigenes, methods fof producing thereof
US5531990A (en) * 1993-12-15 1996-07-02 Health Research, Inc. Method of raising an immune response with an anti-idiotypic antibody having correspondence with human hepatitis B surface antigen
IL118626A0 (en) * 1996-06-11 1996-10-16 Xtl Biopharmaceuticals Limited Anti HBV antibody
US6451572B1 (en) 1998-06-25 2002-09-17 Cornell Research Foundation, Inc. Overexpression of phytase genes in yeast systems
EP1165806B1 (en) * 1999-03-31 2005-08-03 Cornell Research Foundation, Inc. Phosphatases with improved phytase activity
US6841370B1 (en) * 1999-11-18 2005-01-11 Cornell Research Foundation, Inc. Site-directed mutagenesis of Escherichia coli phytase
ES2597503T3 (es) 2001-10-31 2017-01-19 Huvepharma Eood Alimento para animales que contiene fitasa y método
ATE492631T1 (de) * 2002-09-13 2011-01-15 Cornell Res Foundation Inc Verwendung von mutationen zur verbesserung von aspergillus-phytasen
US7919297B2 (en) 2006-02-21 2011-04-05 Cornell Research Foundation, Inc. Mutants of Aspergillus niger PhyA phytase and Aspergillus fumigatus phytase
WO2008017066A2 (en) * 2006-08-03 2008-02-07 Cornell Research Foundation, Inc. Phytases with improved thermal stability
BRPI0721630A2 (pt) 2007-05-02 2013-10-15 Merial Ltd Plasmídeo de dna tendo expressão e estabilidade aperfeiçoadas
US8192734B2 (en) 2007-07-09 2012-06-05 Cornell University Compositions and methods for bone strengthening
CN112680464B (zh) * 2020-12-10 2022-04-26 南京农业大学 一种单甲基砷和三价锑氧化酶基因arsV及其编码的蛋白和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2444713A1 (fr) * 1978-12-18 1980-07-18 Pasteur Institut Procede de production d'un adn comprenant le genome du virus de l'hepatite b et vecteur le comportant
FR2480779B2 (fr) * 1979-08-30 1986-07-18 Anvar Vecteur contenant une sequence nucleotidique de l'antigene de surface du virus de l'hepatite b et procede de fabrication d'une molecule immunogene mettant en oeuvre ce vecteur
US4615974A (en) * 1981-08-25 1986-10-07 Celltech Limited Yeast expression vectors
US4446235A (en) * 1982-03-22 1984-05-01 Genentech, Inc. Method for cloning human growth hormone varient genes
US4546082A (en) * 1982-06-17 1985-10-08 Regents Of The Univ. Of California E. coli/Saccharomyces cerevisiae plasmid cloning vector containing the alpha-factor gene for secretion and processing of hybrid proteins
GB2125047B (en) * 1982-08-09 1986-02-19 Ciba Geigy Ag Yeast hybrid vectors and their use for the production of polypeptides
AU584580B2 (en) * 1982-09-08 1989-06-01 Smith Kline - Rit Hepatitis B virus vaccine
CA1341302C (en) * 1983-02-22 2001-10-09 Rae Lyn Burke Yeast expression systems with vectors having gapdh or pyk promoters and synthesis of foreign protein

Also Published As

Publication number Publication date
ES524942A0 (es) 1985-10-01
KR840005745A (ko) 1984-11-15
JPS5931799A (ja) 1984-02-20
DK372183A (da) 1984-02-17
CA1270217A (en) 1990-06-12
DK372183D0 (da) 1983-08-15
KR890000096B1 (ko) 1989-03-07
IL69423A0 (en) 1983-11-30
US4778761A (en) 1988-10-18
DK169953B1 (da) 1995-04-10
SU1387878A3 (ru) 1988-04-07
ES8802162A1 (es) 1988-04-01
JPS6155950B2 (es) 1986-11-29
ES540895A0 (es) 1988-04-01

Similar Documents

Publication Publication Date Title
ES8802162A1 (es) Un procedimiento para la preparacion de una levadura trans- formada con un plasmido recombinante insertado con el gen del virus de la hepatitis b.
BG60107B2 (bg) Метод за получаване на еукариотен полипептид
EP0278940A3 (en) Hepatitis b virus surface antigens and hybrid antigens containing them
ATE59409T1 (de) Herstellung von oberflaechen-hepatitis-b-antigen in hefe.
AU561343B2 (en) Human immune interferon by recombinant dna
KR880011342A (ko) 비a 비b형 간염 특이 항원을 코딩하는 dna 단편, 이 dna 단편을 함유하는 발현 벡터, 형질전환체 및 이 항원의 제조방법
CA2031164A1 (en) Recombinant herpesvirus of turkeys and live vector vaccines derived thereof
AU554080B2 (en) Production of viral antisens
AU571128B2 (en) Expression of immunologically reactive aids viral protein
EP0216564A3 (en) Infectious recombinant virus, vaccines containing said virus for feline leukemia, and methods for the production thereof
ES8706824A1 (es) Un metodo para preparar proteinas que son inmunologicamente reactivas con anticuerpos para virus asociados con linfadenopatia.
AU1692595A (en) Mammalian expression systems for hepatitis c virus envelope genes
ATE73349T1 (de) Hepatitisoberflaechenantigenpartikelvakzin.
ES8600938A1 (es) Un procedimiento para preparar el antigeno de superficie de la hepatitis b
AU630861B2 (en) Recombinant hiv-2 polypeptides
EP0152030A3 (en) Adult t cell leukemia virus antigen polypeptide
EP0228036A3 (en) Method for producing selected polypeptides in virally infected insect cells and polypeptides isolated therefrom
EP0327180A3 (en) Vaccine containing polypeptides derived from the envelope gene of human immunodeficiency virus type 1
GR3016996T3 (en) Method for the preparation of a protein by yeast using an inductible system, vectors and corresponding transformed strains.
AU4334193A (en) Infectious bovine rhinotracheitis virus mutants and vaccines
ATE53606T1 (de) Mit einem herpes-simplex-virus-gen inseriertes rekombinantes plasmid.
EP0218474A3 (en) Novel dna and polypeptide
Tetsuro et al. Expression of human T-cell leukemia virus type I envelope protein in Saccharomyces cerevisiae
AU2190288A (en) Vector for the expression of proteins of the HIV-2 virus, one of the casual agents of AIDS, cell culture infected or transformed by this vector, proteins obtained, vaccine and antibodies obtained
ES8602935A1 (es) Un vector reversible